BridgeBio Pharma, Inc. BBIO
77.89 USD +3.86 (+5.21%)
At closeNov 4, 2026, 4:00 PM EST
77.89 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
73.52 Day range 78.01
60.55 52-week range 93.42
- YTD
- +1.83%
- 1 year
- +26.92%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 502.08M | 221.90M | 9.30M | 77.65M | 69.72M | |
| 481.11M | 218.02M | 6.86M | 74.21M | 66.60M | |
| -523.41M | -592.97M | -607.37M | -512.20M | -576.63M | |
| -724.93M | -535.76M | -643.20M | -481.18M | -562.54M | |
| -3.78 | -2.88 | -3.95 | -3.26 | -3.90 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 570.12M | 681.10M | 392.59M | 414.62M | 393.95M | |
| 936.02M | 919.34M | 546.38M | 623.04M | 1.01B | |
| 3.01B | 2.38B | 1.89B | 1.87B | 1.88B | |
| 1.86B | 1.73B | 1.74B | 1.72B | 1.73B | |
| -2.09B | -1.47B | -1.35B | -1.25B | -870.41M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -445.91M | -520.73M | -527.72M | -419.49M | -497.93M | |
| -24.49M | 60.78M | 54.03M | 453.15M | -200.83M | |
| 359.29M | 748.46M | 451.54M | -13.13M | 736.45M | |
| -1.10M | -933.00K | -1.31M | 105.18M | -13.25M | |
| -111.10M | 288.51M | -22.15M | 20.52M | 37.69M |